Study: Getting Vaccinated Against COVID-19 Can Improve Mental Health

September 15, 2021 by Alexa Hornbeck
Study: Getting Vaccinated Against COVID-19 Can Improve Mental Health
A man gets a COVID-19 vaccine at a mass vaccination site at the Natick Mall in Natick, Mass. (Matt Stone/The Boston Herald via AP, Pool)

LOS ANGELES, Calif. — A year-long study conducted by researchers from the University of Southern California finds that getting vaccinated against COVID-19 can actually improve mental health.

“We were interested to see what the short-term effects of getting a COVID-19 vaccination would be on people’s mental health, and whether something that can allow you to become less scared of being infected or sick could impact your well-being,” said researcher Francisco Perez-Arce, economist at the University of Southern California Center for Economic and Social Research.

To conduct the study, Perez-Arce and his team provided bi-weekly surveys to 8,003 adults between March 10, 2020 – March 31, 2021. Participants were enrolled using an address-based nationally representative database called the Understanding America Study.

The surveys consisted of four questions, two about anxiety and two about depression, and were issued to those who had received one shot of the COVID-19 vaccine and those who had never received a shot.

Perez-Arce said that for all study participants there were steep increases in mental distresses observed at the start of the pandemic from March- April 2020.

The increases in mental distress dropped after April 2020 as Perez-Arce said all survey participants seemed to adapt to the pandemic quickly.

However, when it came to the time period from December 2020- March 2021, mental distress sharply decreased for those who received one shot but plateaued for those who did not receive any vaccination.

“By comparing the trajectories of these two groups, we learn about the short-term impact of vaccination on mental health,” said Perez-Arce.

One of the limitations of the study is that by January 2021 the population that was primarily eligible to get a vaccine consisted of elderly individuals, those with pre-existing chronic conditions, and medical workers, which Perez-Arce said all likely had an eagerness to get the vaccine as they were more fearful of contracting COVID-19.

“This shows that part of the negative effects of COVID-19 on mental health derive from stress and fear of having bad health outcomes. There’s been a lot of studies that have shown that the economic aspects have been an important part of mental distress, but this study shows that getting relief from the fear of bad health outcomes can certainly improve mental health,” said Perez-Arce.

Perez-Arce said it’s also important to separate the fact that the study analyzes the impact of receiving a COVID-19 vaccine, but not the vaccine campaign overall. 

“The vaccine is the result of a drop in cases, and that drop in cases will have an effect on everyone, including people who didn’t get the shot,” said Perez-Arce. 

Perez-Arce further explained that an unvaccinated individual may still benefit from reduced rates of COVID-19 in the population, as they may be less worried about loved ones, and may benefit from increased social and economic opportunities from lowered disease risk. 

Perez-Arce said a follow-up study might include asking questions about mental health outcomes after March 2021 for people who got vaccinated later on and those who remain unvaccinated, but funding for data collection that was mostly provided by National Institutes of Health ran out as of June 2021. 

“We are trying to get funding for other data collection points that would allow us to answer these questions,” said Perez-Arce. 

A+
a-
  • COVID-19
  • mental health
  • Research
  • University of Southern California
  • In The News

    Health

    Voting

    Research

    April 24, 2024
    by Dan McCue
    FDA Approves New Treatment for Urinary Tract Infections

    WASHINGTON — The Food and Drug Administration approved Pivya (pivmecillinam) tablets for the treatment of female adults with uncomplicated urinary... Read More

    WASHINGTON — The Food and Drug Administration approved Pivya (pivmecillinam) tablets for the treatment of female adults with uncomplicated urinary tract infections.  “Uncomplicated UTIs are a very common condition impacting women and one of the most frequent reasons for antibiotic use,” said Dr. Peter Kim, M.S.,... Read More

    March 27, 2024
    by Dan McCue
    One-Time Treatment Could Revitalize Immune Systems in the Elderly

    PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of... Read More

    PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of immune cell could potentially revitalize the immune systems of the elderly, helping their bodies better react to viral and bacterial threats. The research was carried out... Read More

    March 13, 2024
    by Dan McCue
    Researchers Identify Brain Connections Associated with ADHD

    WASHINGTON — After examining more than 8,000 functional brain images of young people with ADHD, researchers have discovered their systems... Read More

    WASHINGTON — After examining more than 8,000 functional brain images of young people with ADHD, researchers have discovered their systems are tied to atypical interactions between the brain’s frontal cortex and the information processing centers deep inside the brain. The research into attention-deficit/hyperactivity disorder was conducted... Read More

    March 1, 2024
    by Dan McCue
    Solar Imports Surged in 2023, Tariff Waiver Set to Expire

    WASHINGTON — The United States saw an “unprecedented wave” of solar panels being imported from Southeast Asia last year, according... Read More

    WASHINGTON — The United States saw an “unprecedented wave” of solar panels being imported from Southeast Asia last year, according to a new analysis by S&P Global, the financial information and analytics firm.  Relying on data reported to the U.S. Census Bureau, S&P Global’s Market Intelligence... Read More

    February 14, 2024
    by Dan McCue
    COVID Vax, Booster During Pregnancy Bolsters Protections for Newborns

    WASHINGTON — Women who receive an mRNA-based COVID-19 vaccination or booster during pregnancy can provide their infants with significant protection... Read More

    WASHINGTON — Women who receive an mRNA-based COVID-19 vaccination or booster during pregnancy can provide their infants with significant protection against COVID-19 for at least six months after birth, a new study found. The research was conducted by the Infectious Diseases Clinical Research Consortium and published... Read More

    February 12, 2024
    by Dan McCue
    Scientists Set Record for Fusion-Generated Energy

    OXFORDSHIRE, U.K. — Researchers at a joint European testing facility set a record for the amount of energy generated from... Read More

    OXFORDSHIRE, U.K. — Researchers at a joint European testing facility set a record for the amount of energy generated from the process of nuclear fusion, but experts say machines capable of safely supplying that energy to the grid are still decades away. The breakthrough, announced on... Read More

    News From The Well
    scroll top